Novome
United States · $76.5M raised
- Employees
- 11–50
- Business Model
- B2B
- Website
- novomebio.com
- Total Funding
- $76.5M
- Last Round
- $43.5M Series BSep 2022
- Rounds
- 3
About
Novome Biotechnologies engineers living medicines using the microbiome to treat chronic diseases.
Summary
Novome is a Biotech company based in United States. It has raised $76.5M in total across 3 rounds, most recently a $43.5M Series B round in Sep 2022. Investors include Tencent, DCVC (Data Collab) and 5AM Ventures.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2022
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...